Pyrimido[4,5-d]azepines as potent and selective 5-HT2C receptor agonists: Design, synthesis, and evaluation of PF-3246799 as a treatment for urinary incontinence
摘要:
New pyrimido[4,5-d]azepines 7 are disclosed as potent 5-HT2C receptor agonists. A preferred example, 7b had minimal activation at either the 5-HT2A or 5-HT2B receptors combined with robust efficacy in a preclinical canine model of stress urinary incontinence (SUI) and attractive pharmacokinetic and safety properties. Based on this profile, 7b (PF-3246799) was identified as a candidate for clinical development for the treatment of SUI. In addition, it proved to be critical to build an understanding of the translation between recombinant cell-based systems, native tissue preparations and in vivo preclinical models. This was a significant undertaking and proved to be crucial in compound selection. (C) 2010 Elsevier Ltd. All rights reserved.
Synthesis and Structure−Activity Relationships of 2-Pyridones: A Novel Series of Potent DNA Gyrase Inhibitors as Antibacterial Agents
作者:Qun Li、Daniel T. W. Chu、Akiyo Claiborne、Curt S. Cooper、Cheuk M. Lee、Kathleen Raye、Kristine B. Berst、Pamela Donner、Weibo Wang、Lisa Hasvold、Anthony Fung、Zhenkun Ma、Michael Tufano、Robert Flamm、Linus L. Shen、John Baranowski、Angela Nilius、Jeff Alder、Jonathan Meulbroek、Kennan Marsh、DeAnne Crowell、Yuhua Hui、Louis Seif、Laura M. Melcher、Rodger Henry、Steven Spanton、Ramin Faghih、Larry L. Klein、S. Ken Tanaka、Jacob J. Plattner
DOI:10.1021/jm960207w
日期:1996.1.1
Two novel series of 2-pyridones were synthesized by transposition of the nitrogen of 4-quinolones to the bridgehead position. This subtle interchange of the nitrogenatom with a carbon atom yielded two novel heterocyclic nuclei, pyrido[1,2-alpha]pyrimidine and quinolizine, which had not previously been evaluated as antibacterial agents and were found to be potent inhibitors of DNA gyrase. Quinolizines
PYRIMIDINE COMPOUNDS AS SEROTONIN RECEPTOR MODULATORS
申请人:Dvorak A. Curt
公开号:US20070032481A1
公开(公告)日:2007-02-08
Certain pyrimidine-containing compounds are serotonin receptor modulators useful in the treatment of serotonin-mediated diseases.
某些含嘧啶的化合物是有效的血清素受体调节剂,可用于治疗血清素介导的疾病。
Microwave-assisted synthesis of new fluorinated coumarin–pyrimidine hybrids as potent anticancer agents, their DNA cleavage and X-ray crystal studies
作者:Kallappa. M. Hosamani、Dinesh S. Reddy、Hirihalli. C. Devarajegowda
DOI:10.1039/c4ra12222d
日期:——
Rapid and high yielding synthesis of new fluorinated coumarin–pyrimidine hybrids and their application as potent anticancer agents is described.
快速高产量合成新的氟化香豆素-嘧啶杂化物,并将其应用作强效抗癌剂。
Pyrimidine compounds as serotonin receptor modulators
申请人:Janssen Pharmaceutica NV
公开号:US07598255B2
公开(公告)日:2009-10-06
Certain pyrimidine-containing compounds are serotonin receptor modulators useful in the treatment of serotonin-mediated diseases.
某些含嘧啶的化合物是血清素受体调节剂,可用于治疗与血清素相关的疾病。
2-Alkyl-4-aryl-pyrimidine fused heterocycles as selective 5-HT2A antagonists
作者:Brock T. Shireman、Curt A. Dvorak、Dale A. Rudolph、Pascal Bonaventure、Diane Nepomuceno、Lisa Dvorak、Kirsten L. Miller、Timothy W. Lovenberg、Nicholas I. Carruthers
DOI:10.1016/j.bmcl.2008.01.090
日期:2008.3
The synthesis and SAR for a novel series of 2-alkyl-4-aryl-tetrahydro-pyrido-pyrimidines and 2-alkyl-4-aryl-tetrahydropyrimido-azepines is described. Representative compounds were shown to be subtype selective 5-HT2A antagonists. Optimal placement of a basic nitrogen relative to the pyrimidine and the presence of a 4-fluorophenyl group in the pyrimidine 4-position was found to have a profound effect on affinity and selectivity. (c) 2008 Elsevier Ltd. All rights reserved.